Previous 10 | Next 10 |
Zai Lab Limited (ZLAB) Q2 2021 Earnings Conference Call August 10, 2021 08:00 ET Company Participants Billy Cho - Chief Financial Officer Samantha Du - Founder, Chairperson and Chief Executive Officer Tao Fu - Chief Strategy Officer Alan Sandler - President and Head, Global Development, Oncol...
SHANGHAI and SAN FRANCISCO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced financial results for the second quarter of 2021, along with recent product highlights and corporate updates. ...
Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome, a San Diego short-read company, for up to $800 million. Shanghai's Zai Lab and Schrödinger of New York formed a global collaboration to develop a novel oncology pr...
Zai Lab (NASDAQ:ZLAB) and Schrödinger (NASDAQ:SDGR) announce a global discovery, development and commercialization collaboration focused on a novel program in oncology targeting DNA damage response. The companies will be responsible for their own research program expenses, and under...
Agreement provides Schrödinger and Zai Lab with pipeline expansion opportunities in precision oncology Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, and Zai Lab Limited (Na...
China's recent capital market crackdown seems arbitrary but consistent. The Party's actions need to be viewed through the lens of geopolitics, domestic control, and culture. Investors need to pay heed to government's nationalistic agenda. For further details see: Chinese...
4 Top Biotech Stocks To Watch This Month As investors look for the next lucrative industry in the stock market , biotech stocks would often be in sight. It may not be the largest industry nor the most exciting, but it does boast some of the highest potential for returns. For exa...
San Diego-based Kumquat Biosciences announced a $2 billion agreement with a Lilly subsidiary to discover small-molecule drugs that stimulate tumor-specific immune responses in cancer patients. Sirnaomics, a Maryland-Suzhou RNAi therapeutics company, filed to raise $300 million in a Ho...
It was an excruciating week of a severe emotional storm with the share prices undergoing a rollercoaster ride. A deluge of news, speculations, and commentaries overwhelmed the mind. The massive and synchronized sell-off of Chinese equities was akin to a Golden Slam for the critics. It...
As noted in Wall Street Breakfast "Even when you think China risk is priced, it can get worse" Recent Government actions prompt a new degree of caution in further advices; should we go to the point of taking losses now and adjusting score-keeping to reflect committed errors. Our a...
News, Short Squeeze, Breakout and More Instantly...
First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study Zai Lab Limited (NASDAQ: Z...
Manuscript represents the first publication from China’s gynecology oncology field to be published in Cell Publication highlights first-time learnings about the landscape of ovarian cancer microenvironment stratified by HRD and how a PARP inhibitor perturbs it Data suggest ...
2024-07-05 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...